The US Senate has unanimously passed the FDA Modernisation Act, amending outdated regulatory requirements to include modern, human-relevant testing methods like organ-on-a-chip. This significant legislative change aims to reduce reliance on ineffective animal experiments and improve the accuracy of drug development processes. The Act’s potential global impact is expected to